(Q30913359)

6 November 2017

1 reference

title

Database analyses for the prediction of in vivo drug-drug interactions from in vitro data (English)

1 reference

6 November 2017

0 references

0 references

Kiyomi Ito

1

1 reference

6 November 2017

Hayley S Brown

series ordinal

2

1 reference

6 November 2017

J Brian Houston

series ordinal

3

1 reference

6 November 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

British Journal of Clinical Pharmacology

6 November 2017

1 reference

6 November 2017

57

1 reference

6 November 2017

4

1 reference

6 November 2017

473-486

1 reference

Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?

6 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884485

Inhibition-based metabolic drug-drug interactions: predictions from in vitro data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884485

Sense and nonsense in the prediction of drug-drug interactions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884485

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--towards a consensus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884485

Use of in vitro drug metabolism data to evaluate metabolic drug-drug interactions in man: the need for quantitative databases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884485

Quantitative prediction of in vivo drug-drug interactions from in vitro data based on physiological pharmacokinetics: use of maximum unbound concentration of inhibitor at the inlet to the liver

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884485

CYP3A4 drug interactions: correlation of 10 in vitro probe substrates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884485

Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884485

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884485

Pharmacokinetic drug interactions of macrolides

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884485

Effect of omeprazole on diazepam disposition in the rat: in vitro and in vivo studies.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2003.02041.X

FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2003.02041.X

Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2003.02041.X

Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo

21 January 2018

1 reference

12 December 2020

Relationship between enoxacin and ciprofloxacin plasma concentrations and theophylline disposition

1 reference

12 December 2020

Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships

1 reference

12 December 2020

Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver

1 reference

12 December 2020

Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A

1 reference

12 December 2020

10.1111/J.1365-2125.2003.02041.X

Identifiers

DOI

1 reference

6 November 2017

1 reference

6 November 2017

1 reference